Italy begins testing human coronary vaccine

Italy started experimenting today on the human anti-Convid vaccine produced by Italian bio-technology company Ray Thera. The vaccine will be tested on 90 healthy people. 45 will be between 18 and 55 and 45 years of age. The vaccine will be tested in 6 groups [...]
Italy started experimenting today on the human anti-Convid vaccine produced by Italian bio-technology company Ray Thera.
The vaccine will be tested on 90 healthy people.
45 will be between 18 and 55 and 45 years of age.
The vaccine will be tested in six groups of 15 people who will receive three doses of it.
The Elsperiment will be conducted at the Spalanzan Institution of Infectious Diseases in Rome, supported by the Italian Ministry of Health and by the health system of the Lazio region.











